Cargando…

Ozone therapy for high-grade glioma: an overview

High-grade gliomas (grades III and IV) are highly malignant and aggressive brain tumors that present significant treatment challenges. Despite advances in surgery, chemotherapy, and radiation therapy, the prognosis for patients with glioma remains poor, with a median overall survival (mOS) range of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yanchu, Li, Rong, Pu, Rong, Cao, Li, Zhang, Xiaoyan, Yang, Feng, Wang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244787/ https://www.ncbi.nlm.nih.gov/pubmed/37293584 http://dx.doi.org/10.3389/fonc.2023.1161206

Ejemplares similares

Chromatin mutations in pediatric high grade gliomas
por: Voon, Hsiao P. J., et al.
Publicado: (2023)

Mifepristone Repurposing in Treatment of High-Grade Gliomas
por: Llaguno-Munive, Monserrat, et al.
Publicado: (2021)

Contrahemispheric Cortex Predicts Survival and Molecular Markers in Patients With Unilateral High-Grade Gliomas
por: Yuan, Taoyang, et al.
Publicado: (2020)

The efficacy and adverse effects of anlotinib in the treatment of high-grade glioma: A retrospective analysis
por: Shen, Fangcheng, et al.
Publicado: (2023)

Small Molecule Inhibitors in Adult High-Grade Glioma: From the Past to the Future
por: Huang, Wenda, et al.
Publicado: (2022)

Serum Inflammatory Biomarkers Contribute to the Prognosis Prediction in High-Grade Glioma
por: Chen, Xiao-Yong, et al.
Publicado: (2022)

Efficacy of TTFields in high-grade gliomas: a protocol for systematic review and meta-analysis
por: Li, Xinlong, et al.
Publicado: (2023)

Behavior-Oriented Nomogram for the Stratification of Lower-Grade Gliomas to Improve Individualized Treatment
por: Wei, Ruo-Lun, et al.
Publicado: (2020)

Immune Characteristics and Prognosis Analysis of the Proteasome 20S Subunit Beta 9 in Lower-Grade Gliomas
por: Liu, Junzhe, et al.
Publicado: (2022)

OSlgg: An Online Prognostic Biomarker Analysis Tool for Low-Grade Glioma
por: An, Yang, et al.
Publicado: (2020)

A Multi-Institutional Experience in Pediatric High-Grade Glioma
por: Walston, Steve, et al.
Publicado: (2015)

Next Generation CAR T Cells for the Immunotherapy of High-Grade Glioma
por: Petersen, Christopher T., et al.
Publicado: (2019)

Radiosensitization in Pediatric High-Grade Glioma: Targets, Resistance and Developments
por: Metselaar, Dennis S., et al.
Publicado: (2021)

ErbB4 in the brain: Focus on high grade glioma
por: Pitcher, Jamie-Lee, et al.
Publicado: (2022)

Integrin Alpha-2 as a Potential Prognostic and Predictive Biomarker for Patients With Lower-Grade Glioma
por: Lin, Li, et al.
Publicado: (2021)

Commentary on: “A Multi-Institutional Experience in Pediatric High Grade Glioma”
por: Caffo, Maria
Publicado: (2015)

Therapeutic Targeting of Histone Modifications in Adult and Pediatric High-Grade Glioma
por: Williams, Maria J., et al.
Publicado: (2017)

Impact of Radiochemotherapy on Immune Cell Subtypes in High-Grade Glioma Patients
por: Dutoit, Valérie, et al.
Publicado: (2020)

Circulating miRNAs as Diagnostic and Prognostic Biomarkers in High-Grade Gliomas
por: Wu, Jianing, et al.
Publicado: (2022)

Preclinical modeling of lower-grade gliomas
por: Tang, Lilly W., et al.
Publicado: (2023)

The Impact of Timing of Concurrent Chemoradiation in Patients With High-Grade Glioma in the Era of the Stupp Protocol
por: Warren, Kwanza T., et al.
Publicado: (2019)

Microvascular characteristics of lower-grade diffuse gliomas: investigating vessel size imaging for differentiating grades and subtypes
por: Guo, Hong, et al.
Publicado: (2018)

Development and Validation of a Radiosensitivity Prediction Model for Lower Grade Glioma Based on Spike-and-Slab Lasso
por: Du, Zixuan, et al.
Publicado: (2021)

Potential roads for reaching the summit: an overview on target therapies for high-grade gliomas
por: Giotta Lucifero, Alice, et al.
Publicado: (2020)

Factors Involved in Preoperative Edema in High-Grade Gliomas
por: Saito, Takashi, et al.
Publicado: (2022)

FGFR1 Expression and Role in Migration in Low and High Grade Pediatric Gliomas
por: Egbivwie, Naomi, et al.
Publicado: (2019)

Radiomics Features Predict CIC Mutation Status in Lower Grade Glioma
por: Zhang, Luyuan, et al.
Publicado: (2020)

Comparative dosimetric study of radiotherapy in high-grade gliomas based on the guidelines of EORTC and NRG-2019 target delineation
por: Yan, Ouying, et al.
Publicado: (2023)

The Epidemiological Characteristics and Prognostic Factors of Low-Grade Brainstem Glioma: A Real-World Study of Pediatric and Adult Patients
por: Liu, Zhuoyi, et al.
Publicado: (2020)

Rationale and Clinical Implications of Fluorescein-Guided Supramarginal Resection in Newly Diagnosed High-Grade Glioma
por: Wang, Linda M., et al.
Publicado: (2021)

The Epigenetics of Glioma Stem Cells: A Brief Overview
por: Valor, Luis M., et al.
Publicado: (2020)

Prognostic Value of an Autophagy-Related Five-Gene Signature for Lower-Grade Glioma Patients
por: Guo, Jin-Cheng, et al.
Publicado: (2021)

Pediatric High Grade Glioma: a Review and Update on Tumor Clinical Characteristics and Biology
por: Fangusaro, Jason
Publicado: (2012)

The Subventricular Zone, a Hideout for Adult and Pediatric High-Grade Glioma Stem Cells
por: Lombard, Arnaud, et al.
Publicado: (2021)

Role of Hyperbaric Oxygenation Plus Hypofractionated Stereotactic Radiotherapy in Recurrent High-Grade Glioma
por: Arpa, Donatella, et al.
Publicado: (2021)

T-Cell Immunotherapy for Pediatric High-Grade Gliomas: New Insights to Overcoming Therapeutic Challenges
por: Haydar, Dalia, et al.
Publicado: (2021)

Uncovering Spatiotemporal Heterogeneity of High-Grade Gliomas: From Disease Biology to Therapeutic Implications
por: Comba, Andrea, et al.
Publicado: (2021)

An Overview of Epigenetic Methylation in Pancreatic Cancer Progression
por: Zhao, Yuhao, et al.
Publicado: (2022)

DNA Methylation-Driven Genes for Developing Survival Nomogram for Low-Grade Glioma
por: Guo, Yingyun, et al.
Publicado: (2022)

Bevacizumab in recurrent WHO grades II–III glioma
por: Annakib, Soufyan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6f3bfksjbrd29alm3h0n5uqav6